KMG Fiduciary Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.9M Buy
74,914
+2,040
+3% +$379K 1.03% 19
2025
Q1
$15.3M Sell
72,874
-10,403
-12% -$2.18M 1.27% 13
2024
Q4
$14.8M Buy
83,277
+2,805
+3% +$498K 1.23% 13
2024
Q3
$15.9M Sell
80,472
-5,585
-6% -$1.1M 1.37% 12
2024
Q2
$14.8M Buy
86,057
+1,744
+2% +$299K 1.45% 13
2024
Q1
$15.4M Sell
84,313
-808
-0.9% -$147K 1.59% 12
2023
Q4
$13.2M Buy
85,121
+875
+1% +$136K 1.54% 13
2023
Q3
$12.6M Buy
84,246
+2,057
+3% +$307K 1.66% 13
2023
Q2
$11.1M Buy
82,189
+15,054
+22% +$2.03M 1.43% 13
2023
Q1
$10.7M Buy
67,135
+1,880
+3% +$300K 1.53% 12
2022
Q4
$10.5M Buy
65,255
+4,446
+7% +$719K 1.73% 8
2022
Q3
$8.16M Buy
60,809
+8,967
+17% +$1.2M 1.57% 11
2022
Q2
$7.94M Sell
51,842
-1,575
-3% -$241K 1.48% 13
2022
Q1
$8.66M Buy
53,417
+716
+1% +$116K 1.38% 14
2021
Q4
$7.14M Buy
52,701
+8,924
+20% +$1.21M 1.1% 21
2021
Q3
$4.72M Buy
43,777
+17,180
+65% +$1.85M 0.8% 33
2021
Q2
$3M Buy
26,597
+1,692
+7% +$191K 0.53% 48
2021
Q1
$2.7M Buy
24,905
+3,827
+18% +$414K 0.53% 49
2020
Q4
$2.25M Buy
21,078
+3,249
+18% +$346K 0.47% 50
2020
Q3
$1.56M Buy
17,829
+698
+4% +$61.2K 0.39% 57
2020
Q2
$1.68M Sell
17,131
-195
-1% -$19.1K 0.47% 54
2020
Q1
$1.32M Buy
17,326
+4,453
+35% +$339K 0.43% 56
2019
Q4
$1.14M Buy
12,873
+288
+2% +$25.5K 0.35% 52
2019
Q3
$953K Sell
12,585
-6,254
-33% -$474K 0.32% 59
2019
Q2
$1.37M Buy
18,839
+5,559
+42% +$404K 0.5% 41
2019
Q1
$1.07M Buy
13,280
+6,151
+86% +$496K 0.41% 48
2018
Q4
$657K Buy
+7,129
New +$657K 0.3% 61